Role of Cerebral Angiography in Diagnosing and Managing Cerebral Vasculitis
Cerebral angiography is the most sensitive imaging method for assessing large-to-medium vessel cerebral vasculitis but has limited utility in small vessel vasculitis, which often requires brain biopsy for definitive diagnosis. 1
Diagnostic Algorithm for Suspected Cerebral Vasculitis
Initial Imaging
MRI Brain with Contrast
- First-line imaging modality with sensitivity approaching 100% when normal 2
- Characteristic findings:
MRA Head
Advanced Imaging
Vessel Wall Imaging (Contrast-enhanced MRI)
Cerebral Angiography (Digital Subtraction Angiography)
Vasculitis Classification and Imaging Approach
Large-to-Medium Vessel Vasculitis
- Imaging of choice: Cerebral angiography or CTA/MRA
- Findings: Beaded appearance of vessels, stenosis, occlusion, vessel wall enhancement
- Utility of angiography: High sensitivity for detecting abnormalities
Small Vessel Vasculitis
- Imaging of choice: MRI brain (for parenchymal changes)
- Findings: Multiple infarcts in different vascular territories
- Utility of angiography: Limited - typically negative 1
- Definitive diagnosis: Often requires brain biopsy 1
Limitations and Pitfalls
False Negatives
Overlap with Other Conditions
Evolving Role of Non-invasive Imaging
Management Implications
- Positive angiographic findings in the appropriate clinical context support immunosuppressive therapy 5
- Treatment typically includes combination of steroids and cyclophosphamide for induction 5
- Serial imaging is important for monitoring treatment response, though vessel wall changes may persist despite clinical improvement 2
Key Points for Clinical Practice
- A normal MRI effectively rules out CNS vasculitis with near 100% sensitivity 2
- Cerebral angiography remains valuable for large-to-medium vessel vasculitis but has limited utility in small vessel disease
- The combination of clinical, laboratory, and imaging findings is essential for diagnosis, as no single test is pathognomonic 6
- Protect patients from unnecessary immunosuppressive therapy when non-inflammatory differential diagnoses haven't been excluded 6